Latest News Archive

Please select Category, Year, and then Month to display items

Ghana High Commissioner visits the UFS

24 June 2022 | Story Dr Nitha Ramnath

“We are trying to close the divide between Ghanaian and South African higher education institutions. Many Ghanaians look to UK and US universities as their first option. However, the same level of education, at a far less rate, is offered at South African higher education institutions – and the University of the Free State in particular.”

These were some of the sentiments shared by His Excellency Mr Charles Asuako Owiredu, High Commissioner of the Republic of Ghana to South Africa, during his recent visit to the University of the Free State.

The High Commissioner, accompanied by the Deputy High Commissioner and Head of Protocol, was hosted by Prof Francis Petersen. After a successful meeting, the students and academics from the Ghanaian community were also engaged. “The Vice-Chancellor was full of praise for the Ghanaian students and their performance at the UFS,” said the High Commissioner.

Prof Chitja Twala, Vice-Dean in the Faculty of the Humanities, highlighted the longstanding relationship that the UFS has with the University of Ghana. “We have a good relationship with the Department of History at the University of Ghana, and we are looking forward to collaboration with the institution,” added Prof Twala.

The High Commissioner felt strongly about cementing the relationships that already exist between the UFS and universities in Ghana and will lobby for education to be included in the master framework used as an operational document between the two countries. Faculty exchanges between the UFS and Ghanaian universities were also encouraged by the High Commissioner.

The High Commissioner encouraged Ghanaian students and academics at the UFS to suggest ways to deepen the relationship between the UFS and Ghanaian institutions.

Dr Prince Sarpong, Senior Lecturer in the School for Financial Planning Law at the UFS, proposed a collaboration between the UFS and Ghanaian institutions in the field of financial planning, whereby there could be an opportunity to reach out and expand the practice of financial planning to institutions in Ghana. The High Commissioner was eager to know more about financial planning and its location within law.

Ghanaian students who attended the meeting shared their experiences and perspectives about the UFS and indicated that an excellent relationship exists with project supervisors while pursuing their studies remotely.

According to Ghanaian students based on the UFS campuses, the UFS is doing great work by engaging students from Ghana in the UFS programme. However, students indicated that challenges were experienced with the South African Qualifications Authority (SAQA).

Dr Cornelius Hagenmeier, Director of the Office for International Affairs at the UFS, assured students that the aspect of SAQA is important and will be looked into, as it relates to the recruitment of students.

The High Commissioner also suggested that the Ghana Accreditation Board engage with SAQA.

A UFS delegation will be visiting Ghana in October to explore the opportunities in agriculture, entrepreneurship, and the Business School.

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept